Latest Blog Posts Tagged "Parkinson's Progression Markers Initiative"
October 13, 2017
Analysis from the MJFF-led PPMI points to potential use of these biomarkers for testing drug engagement but likely not for tracking short-term progression.
October 03, 2017
David Levine, MD, MPH, shares his experiences as a participant in the Levodopa Response Trial and thoughts on PD scientists using his data to advance research.
August 17, 2017
A new paper shows 67% of study participants who showed smell loss and dopamine loss in the brain developed PD over a four-year period. This strategy could help select people for research studies.
August 02, 2017
Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.
July 31, 2017
A new study was launched to investigate if man's best friend can play a role in PD diagnosis.
June 23, 2017
Researchers have developed a tool to predict cognitive decline in PD for use in designing clinical studies. The team analyzed data from multiple studies including PPMI.
June 02, 2017
Sue Lifschiz of Santa Rosa, California was diagnosed with PD in 2002. She joined PPMI to find a biomarker for earlier diagnosis and better disease tracking.
May 17, 2017
Analysis of data from the MJFF-sponsored Parkinson's Progression Markers Initiative gives window into how and why cognitive problems develop in PD
April 18, 2017
A recent study using data from PPMI has identified risk factors that may predict the development of early psychosis in Parkinson's.
February 14, 2017
A new study suggests that evaluating levels of a certain protein in the blood may help distinguish Parkinson's from certain atypical parkinsonisms.